Pharmaceuticals
Category VIEW ALL
A deployable nanostructures from DNA
Technology No. 2026-CHOI-71297
Engineering of assembloid culture for an integrated 3D tissue formation
Technology No. 2025-PARK-71242
Small molecule anti-bacterials to treat Neisseria gonorrhoeae Infections
Technology No. 2020-RAMA-68860
Evaluation of beta/gamma-disubstituted alpha-methylene esters and lactones vs MRSA infection
Technology No. 2020-RAMA-68859
Thermally Activated Ultrasound Contrast Agents
Technology No. 2019-SOLO-68683
Novel Vaccine Formulations for Mycobacterium Tuberculosis and use of Thereof
Technology No. 2019-MITT-68665
Evaluation of Alpha-methylene and Alpha-aminomethyllactones, Lactams, and Related Analogs against C. difficile
Technology No. 2018-RAMA-68247
Novel Adenoviral Vector System for Gene Delivery
Technology No. 2018-MITT-68142
A Novel Peptide-mediated Enhanced Drug Delivery across Epithelial Barrier
Technology No. 2017-BHUN-67963
Synthetic Mimics of Malonyl-CoA as Fatty Acid Synthase Inhibitors
Technology No. 2017-LOHM-67912
SHG Microscopy to Guide Targeted Measurements by Raman Spectroscopy and Synchrotron X-ray Diffraction
Technology No. 2015-SIMP-66994
Development of Degradation Resistant Peptide Based Biosensors for the Selective Measurement of Kinase Activity
Technology No. 2014-PARK-66869
Using Peptide-based Novel Biosensors to Detect Anaplastic Lymphoma Kinase Activity by Sensitization of Terbium Luminescence
Technology No. 2014-PARK-66791
Inhibiting Leukocyte Binding to Disfunctional Endothelial Cells
Technology No. 2014-PANI-66748
Metabolite Biomarkers for Identifying Liver Cancer Patients
Technology No. 66231
Microfluid Platform to Screen Cancer Drug for Delivery
Technology No. 66164
Use of a Kinase Inhibitor Peptide for Treatment of Cartilage Damage and Disease
Technology No. 66136
Collagen-Targeted Nanoparticles
Technology No. 65708
Use of an MK2 Inhibitor to Enhance Nerve Regeneration
Technology No. 65383
Peptide Inhibitors of MAPKAP Kinase II and Methods of Use
Technology No. 64887
Mouse Monoclonal Antibodies Direct Against Mist 1
Technology No. 64058
Hybridomas Producing Anti-Ah Receptor Monoclonal Antibodies (clones Rpt 1 and Rpt 9)
Technology No. 60105
Adenoviral Vector-based Vaccine for Influenza
Technology No. 64187
Tetrahydro-6H-5-oxa-7-azabenzo(c)phenanthrenes as dopamine agonists
Technology No. 64153
Chromeno[4,3,2-de]isoquinolines as Potent Dopamine Receptor Ligands
Technology No. 99031
Eck (D7) Antibodies as Cancer Diagnostic
Technology No. 98013
Selective inhibitors of vancomycin-resistant enterococcus
Technology No. 2026-FLAH-71325
Solid particles of RNA lipid nanoparticles
Technology No. 2025-ZHOU-71178
Protein solids
Technology No. 2025-ZHOU-71177
Discovery of highly potent HIV-1 protease inhibitors with polycyclic-THF ligands
Technology No. 2020-GHOS-68891
Flexible Non-cationic Nanocapsules for Nucleic Acid Delivery
Technology No. 2020-YEO-68868
Highly Efficient and Optically Active Synthesis of bis-THF Ligand of Darunavir
Technology No. 2020-GHOS-68848
Immunotherapy of Glioblastoma with Multi-functional NK Cells in Combination with Inhibition of Autophagy
Technology No. 2020-MATO-68833
Carbonic Anhydrase Inhibitors for Treatment of Neisseria Gonorrhoeae
Technology No. 2020-FLAH-68832
Novel Pyrimidinones Targeting Adenylyl Cyclase 1 for Treating Chronic Pain
Technology No. 2020-FLAH-68825
Tannic Acid-based Nanocapsules for Sustained Delivery of Immunogenic Cell Death Inducers
Technology No. 2020-YEO-68760
DEVELOPMENT OF AN IN VITRO MODEL OF THE NEUROVASCULAR UNIT FOR BBB PERMEABILITY LINKED NEUROACTIVITY SCREENING
Technology No. 2020-KNIP-68758
Small Molecule Stimulators of the Core Particle of the Proteasome
Technology No. 2020-TRAD-68744
Macrotumor Engineering
Technology No. 2019-LELI-68697
NmrLineGuru: Fast 1D NMR Lineshape Simulation & Analysis with Multi-State Equilibrium Binding Models
Technology No. 2019-POST-68616
pH-Dependent Fluorogenic Amyloid-Beta Reporters
Technology No. 2019-CHOP-68541
CF3-, OCF3-, SCF3- and SF5-containing Antibacterial Agents
Technology No. 2019-SINT-68535
Immunomodulatory and Potent Anticancer Activity of Selective Steroidal Analogs
Technology No. 2019-CHOP-68534
Bilirubin-Coated Radio-Luminescent Particles, and Their Use for Radiation-Induced Photodynamic Therapy
Technology No. 2019-WON-68496
Liposome Formulation with High Drug Capacity
Technology No. 2019-YEO-68485
Discovery of Highly Potent HIV-1 Protease Inhibitors with Crown-THF Ligands
Technology No. 2019-GHOS-68467
Immunoproteasome-Mediated Release of Substances into Diseased Cells
Technology No. 2019-TRAD-68454
Rapid Purification of Biopharmaceuticals by Crystallization
Technology No. 2019-NAGY-68435
Phosphate Esters of Human Calcitonin
Technology No. 2019-TOPP-68428
Small Molecules for Treating Vancomycin Resistant Enterococcus Infections
Technology No. 2019-FLAH-68419
Unnatural Proline-rich Antimicrobial Peptides Targeting Intracellular Pathogenic Bacteria and Antibiotic Conjugates Thereof
Technology No. 2019-CHMI-68405
Methods and Reagents to Label Bacteria and Virus and Identify their Interacting Proteins
Technology No. 2019-TAO-68397
Nanoparticles for Sepsis Treatment
Technology No. 2019-YEO-68355
New Target Identified for Cancer Therapy and Its Inhibitor
Technology No. 2018-DAI-68268
Repurposed Drug for Clostridium Difficile Infection
Technology No. 2018-SELE-68251
Novel Inhalation Formulations of Colistin and Meropenem
Technology No. 2018-ZHOU-68233
Suspension-based Oral Solid Doses
Technology No. 2018-REKL-68230
Live Cell Conjugation Chemistry for Imaging, Sensing and Cell Therapy
Technology No. 2018-CHOP-68209
Liposomal Formulation of Combinational Antibiotics
Technology No. 2018-ZHOU-68205
Targeted Antimicrobial Photodynamic Therapy using GaPpIX Conjugates
Technology No. 2018-WEI-68200
N-(1,3,4-oxadiazol-2-yl)benzamide antibacterial agents
Technology No. 2018-SINT-68199
Combination Pharmaceutical Formulations
Technology No. 2018-ZHOU-68184
Novel Selective Inhibitors for Protein alpha-N-terminal Methyltransferases
Technology No. 2018-HUAN-68180
Arylnapthalene Vacuolar-ATPase Inhibitors as Anti-viral Agents
Technology No. 2018-DAVI-68178
Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors
Technology No. 2018-CUSH-68109
Cleavable Conjugates of Antibiotics and an Antibacterial Cell-Penetrating Peptide
Technology No. 2018-CHMI-68009
Novel Scaffold of Adenyly Cyclase Inhibitors for Chronic Pain and Opioid Dependence
Technology No. 2017-WATT-67991
Novel Macrocyclic HIV-1 Protease Inhibitors to Combat Multidrug-Resistant HIV-1 Variants
Technology No. 2017-GHOS-67965
G-protein Biased Delta Opioid Receptor Agonists for Treatment of Alcohol use Disorders and Co-morbid Disorders
Technology No. 2017-VANR-67884
Synthesis and Antimicrobial Activity of Novel Lactones
Technology No. 2017-DAI-67879
Novel Adenyly Cyclase Inhibitors for Chronic Pain and Opioid Dependence
Technology No. 2017-WATT-67867
Open Gradient Exposure Platform for Cell Culture
Technology No. 2017-LELI-67828
Dual Kinase/demethylase as Inhibitors of Proliferative Diseases
Technology No. 2017-SINT-67825
Quinic Acid-Modified Nanoparticles
Technology No. 2017-YEO-67767
Discovery and Design of Selective Ubiquitin Specific Protease (USP) Inhibitors
Technology No. 2017-PEPE-67704
Diagnostic Panel of Modified Proteins for Breast Cancer
Technology No. 2017-TAO-67681
Novel Tricyclic P2-Ligand Containing Potent HIV-Protease Inhibitor Against HIV/AIDS
Technology No. 2017-GHOS-67663
4-substituted-3-isoquinoline Amides and Amidines as Anticancer Agents
Technology No. 2016-SINT-67603
Albumin-coated Nanocrystals
Technology No. 2016-YEO-67581
Enantioselective Total Synthesis of Both Antipodes in the Proposed Structure of Macrolide Cytotoxic Agent Callyspongiolide
Technology No. 2016-GHOS-67560
Anti-Fouling Control of Plug-Flow Crystallization via Heating and Cooling Cycle
Technology No. 2016-KOSW-67539
A Digital Micrograph Script for Detection of Astigmatism in TEM Images
Technology No. 2016-JIAN-67519
Pyrimidinephenylthiazoles as Antimicrobials
Technology No. 2016-CUSH-67515
A Chimeric EGF-Targeted Bacterial Toxin as Therapeutic Agent Against Bladder Cancer
Technology No. 2016-AGUI-67476
A Method for the Expression and Purification of USP17
Technology No. 2016-MESE-67455
Broad-Spectrum Non-Covalent Anti-Coronavirus Therapeutics for Implementation in Zoonotic Outbreaks
Technology No. 2016-STJO-67409
Nonfouling TEM Grid Coatings for Specific Capture of Target Proteins from Cell Lysates
Technology No. 2016-THOM-67374
Peptoid Linked Fragments as PIP Box Antagonists
Technology No. 2016-DAVI-67362
MiniPharm: Miniaturized Continuous End-to-End Manufacturing of Solid Pharmaceuticals
Technology No. 2015-NAGY-67209
Preparation and Applications of Polyrotaxanes Bearing Mixed Cyclodextrin Species
Technology No. 2015-THOM-67198
Phosphate Ester Derivatives of Glucagon
Technology No. 2015-TOPP-67192
Novel, Direct Contact Blood Brain Barrier Triculture
Technology No. 2015-KNIP-67191
PL-PatchSurfer: Molecular Surface-based Method for Exploring Protein-ligand Interactions
Technology No. 2015-KIHA-67111
Patch-Surfer 2.0: Efficient and Accurate Algorithm for Comparing Ligand-Binding Sites of Proteins
Technology No. 2015-KIHA-67110
Aryl Isonitriles as A New Class of Antimicrobial Compounds
Technology No. 2015-DAI-67104
Repurposing Nonantimicrobial Drugs to Treat Bacterial Infections
Technology No. 2015-SELE-67097
Adenylyl Cyclase Inhibitors for Neuropathic and Inflammatory Pain Treatment
Technology No. 2015-DAI-67035
Radioluminescent Particles for Enhancement of Radiation Cancer Therapy
Technology No. 2015-WON-67028
Difference Gel Electrophoresis of Phosphoproteome
Technology No. 2014-TAO-66895
A Chimeric EGF-Targeted Bacterial Toxin as Therapeutic Agent against Bladder Cancer
Technology No. 2014-AGUI-66886
Artificial, Multivalent Fibronectin-Binding Ligands for the Targeting of Bladder Tumor Cells
Technology No. 2014-AGUI-66861
Dual Action, Unnatural Proline-rich Peptides Target Elusive Intracellular Pathogenic Bacteria
Technology No. 2014-CHMI-66831
A Class of Exceptionally Potent HIV-1 Protease Inhibitors Containing Novel Bridged Tp-THF and Other Variants as P2-ligands
Technology No. 2014-GHOS-66828
Novel Anticancer Compounds
Technology No. 2014-GHOS-66703
Disease-on-a-Chip for Detection and Treatment of Neoplasias of Exocrine Glands
Technology No. 2014-LELI-66695
Compounds and Methods for Treating HIV
Technology No. 2014-GHOS-66624
Inhibition of Memapsin 1 Cleavage in the Treatment of Diabetes
Technology No. 2013-GHOS-66610
Polymeric Cyclodextrin Carriers as NPC Therapeutics
Technology No. 2013-THOM-66383
Antimicrobial Activity of Novel Substituted Thiazoles Against Methicillin-Resistant Staphylococcus Aureus (MRSA)
Technology No. 2013-CUSH-66348
Novel High Throughput Technology to Identify Direct Upstream Kinases
Technology No. 66261
Materials and Methods Analyzing Cellular Entrance Pathways
Technology No. 66219
Development of Affinity Capture Materials for Protein Structural Analysis
Technology No. 66004
Chitosan Derivative for Endotoxin Inactivation
Technology No. 65894
Indenoisoquinoline Topoisomerase I Inhibitors Substituted with Carbohydrates
Technology No. 65707
Vaccine Linkers to Attach Proteins to Aluminum Hydroxide Adjuvants
Technology No. 65683
HIV-1 Protease Inhibitors Fused Tris-Tetrahydrofuran (Tris-THF) as P2-ligand
Technology No. 65566
The Release of Trifluoroacetate and Applications to Synthesis
Technology No. 65561
Affinity Stabilization of Protein Drugs
Technology No. 65558
2nd Generation FT Inhibitors
Technology No. 64935
Potent Dimerization Inhibitors for HIV-1 Protease
Technology No. 64554
Pharmaceutical Materials and methods for Their Preparation and Use
Technology No. 99050
Acid Reflux Induced Laryngospasm as a Potential Mechanism of Sudden Death in Epilepsy
Technology No. 2018-IRAZ-68275
Multiscale Microdevices with Nanopillars for Antibiofouling Sensing and Drug Delivery
Technology No. 2018-LEE-68196
Biosensor for Detecting Viscosity Changes
Technology No. 2017-WERE-67686
Spider Web-inspired Design for Three-dimensional Electronic Devices
Technology No. 2017-LEE-67683
Responsive Elastic Polymers and Methods of Making and Using Same
Technology No. 2016-DENG-67555
Perimeter Fill Insulin Safety Syringe
Technology No. 2015-HULT-67088
Triggerable Oxygen Nanobubbles for Drug Delivery, Diagnosis, and Enhanced Survival
Technology No. 2015-IRUD-66920
Electromagnetic Drug Delivery Using EM Responsive Polypyrrole Nanowires
Technology No. 2014-BORG-66652
Transgenically Modified ApoE KO Rats
Technology No. 2013-GOER-66479
Abl Kinase Phosphorylation in Living Cells
Technology No. 2013-IRUD-66358
Designer Collagen Fibers for Tissue Engineering Applications
Technology No. 65081
Pharmaceutical Based Recovery of Function In Chronic Spinal Cord Injury
Technology No. 61133
P188 as a Treatment for Trauma to the Nervous System
Technology No. 61036
Enhanced Sorbose Selectivity from Glucose Isomerization on Lewis Acid Zeolites by Adjusting Confinement
Technology No. 2019-GOUN-68380
Tandem Redox Agent Method Useful for Improving Proinsulin-S-sulfonate Folding Yield
Technology No. 2014-WANG-66914
A Method for Encapsulation of Nanoparticles in Ionic Crystals
Technology No. 65679
Powder Blending and Segregation Model Subroutine Within Abaqus
Technology No. 2017-WASS-67839
Battery Free Vial Printed Temperature Sensors
Technology No. 2016-RAGH-67408
Array-to-Array Transfer with Associated Chemical Transformation
Technology No. 2023-COOK-70077
Shear Gap Granulation
Technology No. 2023-MORT-70068
A New Molecular Representation for Deep Learning of Molecular Properties Prediction and De Novo Design
Technology No. 2023-LI-69995
Precision Nanostructured Presentation of Glycans at Interfaces for Multivalent Binding Specificity
Technology No. 2022-CLAR-69745
Mixing Control in Therapeutic Samples using Schlieren
Technology No. 2021-ARDE-69507
Deterministic Culturing of Single Cells in 3D
Technology No. 2020-SAVR-69076
Accelerated Microdroplet Synthesis of Benzimidazoles
Technology No. 2020-COOK-69066
High-throughput Label-free Enzymatic Bioassays using Automated DESI-MS
Technology No. 2020-COOK-69031
Scaled-up Microdroplet Organic Synthesis with Solvent Recycling
Technology No. 2020-COOK-68885
CHemical Reaction Integrated System (CHRIS)
Technology No. 2020-SOBR-68858
Multiplexed Inductive Nanoelectrospray Ionization Mass Spectrometry System
Technology No. 2018-COOK-68329
Accelerated Degradation of Pharmaceuticals and Related Chemical Processes
Technology No. 2018-COOK-68124
Electrophoretic Spray Mass Spectrometry
Technology No. 2017-COOK-67948
Determination of Isoaspartate in a Peptide
Technology No. 2017-COOK-67947
Tough Pseudo-IPN Hydrogels for Drug Delivery: Controlling Burst Release and Achieving Mechanically Induced Drug Release
Technology No. 2017-CAKM-67907
Open Boundary Conditions for Quantum Models in Fluids
Technology No. 2017-KUBI-67787
Continuous Lyophilization Roll-to-Roll Manufacturing and Metrology System
Technology No. 2017-CAKM-67672
Combination of Cholesterol Esterification Inhibitors with Existing Therapies for Cancer Treatment
Technology No. 2017-CHEN-67647
Dual Frequency Ion Isolation in Quadrupole Ion Traps
Technology No. 2016-COOK-67503
Online Quantitative Monitoring of a Reacting Mixture
Technology No. 2016-COOK-67357
A Smart Capsule with GI-tract-location-specific Payload Release
Technology No. 2015-ZIAI-67007
Nontoxic Raman Tags for Study of Cell Functions
Technology No. 2014-CHEN-66885
Cleansing of Surfactant-Coated Nanoparticles
Technology No. 2014-WEI-66709
Reference-free Spatial Heterodyne Detection of Intracellular Dynamics
Technology No. 2020-NOLT-68887
Amine-boranes as bifunctional reagents for direct amidation of carboxylic acids
Technology No. 2020-RAMA-68861
Fourier Transform Fluorescence Recovery after Photobleaching (FT-FRAP) with Patterned Illumination
Technology No. 2020-SIMP-68794
Application of Wireless Sensor Networks to Lyophilization for Enhanced Process Monitoring and Control
Technology No. 2019-ALEX-68533
Microelectromechanical Gas Sensor Based on Knudsen Thermal Force
Technology No. 2015-ALEX-67217
Poly(propylene carbonate)(PPC)-Based Amphiphilic Block Copolymers, and Methods of Use Thereof
Technology No. 2014-WON-66901
Ligand-mediated Targeting of Cytokine Interleukin-27 Enhances its Bioactivity
Technology No. 2020-FIGU-68875
Novel compositions for treating colitis and/or preventing colon cancer
Technology No. 2019-JIAN-68598
Photodynamic Activity of Vitamin-Chlorin Conjugates at Nanomolar Concentrations against Triple Negative Breast Cancer Cells
Technology No. 2018-ISAA-68156
A Dock Derived Compound against Laminin Receptor (37 LR) for Anti-tumor Treatment
Technology No. 2017-FIGU-67894
Smartphone Application Linking Pharmacy Students to Pharmacy Companies and Employment Resources
Technology No. 2015-LINN-66981
Long-Chain Carboxychromanols and Analogs are Anti-Inflammatories
Technology No. 64885
Targeted, consistent action of polyols on gut microbiota composition and metabolites
Technology No. 2025-HAMA-71252
Virtual Thermocouple: A Non-Invasive Product Temperature Measurement Approach for Controlled Lyophilization
Technology No. 2021-ALEX-69270
WINGS (Wireless Ice Nucleation Gas Sensor)
Technology No. 2021-ALEX-69242
Using of Chia Seed (Salvia hispanica) Mucilage and a Polyol Mixture as Bio-based Film Material for Packaging
Technology No. 2021-LICE-69229
Extraction of Chia Seed Mucilage and Protein using a Combination of Ultrasonication and Microwave-assisted Hydrolysis
Technology No. 2020-LICE-68853
A New Low pH Gel-forming Soluble Polysaccharide
Technology No. 2019-HAMA-68698
Spray Freeze Drying - New Method to Prepare Frozen Particles Allows for Bulk Manufacturing
Technology No. 2018-ALEX-68290
Preparation of Highly Effectively Fusible Liposomes Reconstituted with Phage Portal Proteins for Nanopore Sensing Technology
Technology No. 2016-JING-67338
Calibration-free moisture content sensor and related methods
Technology No. 2024-LU-70552
Tunable Synthetic Transcriptional Regulators that are Responsive to Environmental Triggers
Technology No. 2017-SOLO-67892
Rapid plant protein extraction
Technology No. 2025-CHEN-71029
Chlorin Conjugates for Photodynamic Chemotherapy for Triple-Negative Breast Cancer
Technology No. 2023-ISAA-70121
Development of a novel cytokine-like Propeptide gene therapy platform
Technology No. 2023-FIGU-70017
Fluorescence-based Assay for Novel E3 Ligase Ligand Identification
Technology No. 2023-DAS-69989
Computational method for predicting protein function
Technology No. 2020-KIHA-68982
Fluorescent Assay for Determining Phosphoribosyl Ubiquitination
Technology No. 2020-DAS-69098
Bacteriophage formulations
Technology No. 2025-ZHOU-70957
Gel forming polymers for improved oral peptide formulations
Technology No. 2025-TAYL-70925
Materials, methods and sampling devices for preserving and extracting extracellular vesicles in biofluids
Technology No. 2025-TAO-70811
5/5-5/6-BISARYL COMPOUNDS AS TRANSFORMING GROWTH FACTOR-β ACTIVATED KINASE, TAK1, INHIBITORS
Technology No. 2025-SINT-70883
MATERIALS AND METHODS FOR THE PRODUCTION OF PHENYLALANINE
Technology No. 2025-MORG-70934
Software to generate mega chemical library
Technology No. 2025-LI-70824
Expressible HCV Nucleic Acid and Encoded Glycoprotein Antigens and Methods
Technology No. 2025-KUHN-71090
carbonic anhydrase leads for treatment of bacterial infections
Technology No. 2025-FLAH-71261
Scientific Bespoke Artificial Intelligence Agents Optimized for Research Goals
Technology No. 2025-CHOP-71024
Targeting Cdc14 phosphatase for anti-fungal agents
Technology No. 2024-ZHAN-70728
SHP2 Degraders for Anti-cancer Therapy
Technology No. 2024-ZHAN-70417
TC-PTP/PTPN2 Degraders for Cancer Immunotherapy
Technology No. 2024-ZHAN-70394
Engineered Polymeric Excipients for Enhancing the Stability of Protein Biologics
Technology No. 2024-WON-70668
Microwave Assisted Catalytic Amidation of Organic Amines with Carboxylic Acids
Technology No. 2024-THOM-70677
PDE Stable Endo-phosphorothioate Substituted 2'3'-cGAMP Analogues as STING Agonist
Technology No. 2024-SINT-70418
5-6-5/6 Scaffold as Selective Kinase Inhibitor Moiety with Low Activity Against Immune and Cardiovascular Anti-targets
Technology No. 2024-SINT-70378
5/6-5/6-Bisaryl Substituted with Saturated Cyclic Heterocycles as TAK1 Inhibitors
Technology No. 2024-SINT-70377
Discovery of cyclic peptide natural product inhibitors of free living amoeba
Technology No. 2024-PARK-70715
mRNA Delivered Cell-surface Targeted and Epitope-focused Glycoprotein Antigens for HCV Vaccine
Technology No. 2024-KUHN-70514
A Sperm Glycoprotein-based Contraceptive Vaccine
Technology No. 2024-HOGE-70624
Enhanced immunotherapy of "cold" solid tumors using Tumor tropic S. Typhimurium expressing anti-cancer proteins
Technology No. 2024-HE-70612
Analogs of Diphyllin
Technology No. 2024-DAVI-70723
Omics Automation using Large Language Models
Technology No. 2024-CHOP-70566
PTP1B/TC-PTP Dual Protein Degraders
Technology No. 2023-ZHAN-70087
Nanopuff: Albumin-coated siRNA-bound polydopamine nanoparticles
Technology No. 2023-YEO-70458
Combination of Phosphatidyl Serine Blockade and STING Stimulation for Cancer Immunotherapy
Technology No. 2023-YEO-70023
Excipient-Free Lyophilization of Aqueous Polymer Micelle Suspensions
Technology No. 2023-WON-69925
Precision 3D Printing Method for Customizable Pharmaceutical Mini-Tablets
Technology No. 2023-SUND-70094
3H-pyrazolo[4,3-f]quinoline-based Compounds as STING Antagonists
Technology No. 2023-SINT-70181
Inhibitors of Solvent Front Mutated RET Kinase
Technology No. 2023-SINT-70021
Cyclic Peptide Stimulators of the Proteasome
Technology No. 2023-PARK-70287
Nrf2 Based Stapled Peptides for Sensitization of Cancers to Chemotherapeutics
Technology No. 2023-PARK-69958
Software: The Utility of CDK9 Inhibitors for Restricting Bladder and Cervical Cancers in Human and Dog
Technology No. 2023-KAZE-70312
Prodrugs of Nicotinamide N-Methyltransferase (NNMT) Inhibitors as Novel Therapeutic Agents
Technology No. 2023-HUAN-70285
PRMT Inhibitors
Technology No. 2023-HUAN-70160
A Novel Nanoparticle Adjuvant for Cancer Vaccines
Technology No. 2023-HOGE-70112
Designing HIV-1 Protease Inhibitors Using Imatinib & Nilotinib Templates for Effective HIV/AIDS Treatment
Technology No. 2023-GHOS-70150
Bacterial Carbonic Anhydrase Inhibitors with Improved Pharmacokinetics and Efficacy
Technology No. 2023-FLAH-70278
Covalent Inhibitors as Anti-malarial Agents
Technology No. 2023-FLAH-70246
Natural Product-Inspired Molecules for Covalent Inhibition of SHP2 Tyrosine Phosphatase
Technology No. 2023-DAI-70254
Repurposing Phenol & Phosphate Anticancer Drugs as Cationic Lipid Salts in Solid Lipid Nanoparticles Focused on Etoposide
Technology No. 2023-BYRN-69951
CAR-neutrophils Produced In Vivo to Treat Cancer
Technology No. 2023-BAO-70025
Treatment of Lowe Syndrome
Technology No. 2023-AGUI-69998
Nanoparticle-based Abuse Deterrent Formulations
Technology No. 2022-YEO-69643
Immunoactive Nanocarrier of Immunogenic Cell Death Inducers
Technology No. 2022-YEO-69546
Sequence-Controlled Aliphatic Copolyesters
Technology No. 2022-WON-69547
Continuous Flow Synthesis of Lorazepam
Technology No. 2022-THOM-69904
Continuous Flow Synthesis of A2E
Technology No. 2022-THOM-69651
Polymer Salts for Improved Drug Delivery from Amorphous Solid Dispersions
Technology No. 2022-TAYL-69671
Plasticizers to Improve Release Performance of Amorphous Solid Dispersions
Technology No. 2022-TAYL-69586
Materials and Method to In Situ Isolate Phosphoproteins in Extracellular Vesicles and Exosome
Technology No. 2022-TAO-69815
Benzamide or N-hydroxybenzamide Kinase Inhibitors Derived from Doebner-Povarov Reaction
Technology No. 2022-SINT-69859
Nicotinamide-based Compounds as Potent Inhibitors of Translational- and Transcriptional-related Kinases
Technology No. 2022-SINT-69726
Enhanced Cell-potent Peptidomimetic Inhibitors for NTMT1/2
Technology No. 2022-HUAN-69636
PROTEIN:PROTEIN INTERACTION INHIBITORS
Technology No. 2022-HU-69918
Highly Efficient and Optically Active Synthesis of Crown-THF Ligand
Technology No. 2022-GHOS-69804
Potent 2420-Class of Protease Inhibitors for Treatment of COVID-19
Technology No. 2022-GHOS-69733
Potent Protease Inhibitors for Treatment of COVID-19
Technology No. 2022-GHOS-69724
Design and Synthesis of bi-aryl Methylated Lactam Derivatives to Inhibit the BRD7 Bromodomain Function in Prostate Cancer
Technology No. 2022-DYKH-69819
Cyanide Countermeasures
Technology No. 2022-DAVI-69921
Catalysis-Enabled Concise Total Synthesis of the Tricyclic Prostaglandin D2 Metabolite Methyl Ester
Technology No. 2022-DAI-69694
Polymyxin Combinational Formulations
Technology No. 2021-ZHOU-69256
Inhibitors of Cyclic Mononucleotide and Cyclic Dinucleotide Phosphodiesterases
Technology No. 2021-SINT-69252
Antibiotic Discovery via BICyCLE (Biologically Inspired Chemically Created Leads)
Technology No. 2021-PARK-69383
Computational Method for Modeling Protein Assembly with More Than Two Protein Subunits
Technology No. 2021-KIHA-69437
Computational Method for Modeling Protein Pairwise Assembly
Technology No. 2021-KIHA-69434
Computational Method for Modeling Disordered Protein Assembly
Technology No. 2021-KIHA-69433
Cell-potent and Selective Inhibitors for Nicotinamide N-methyltransferase
Technology No. 2021-HUAN-69352
COMPOUNDS FOR THE TREATMENT OF SARS
Technology No. 2021-GHOS-69511
Design and Synthesis of Novel SARS-CoV-2 3C Inhibitors
Technology No. 2021-GHOS-69510
Tris-Amide Based Novel Anti-COVID-19 Compounds
Technology No. 2021-GHOS-69492
MODIFIED Discovery of Potent anti-Mpro Inhibitors for Covid-19 Treatment using Alpha-ketoamide Derivatives
Technology No. 2021-GHOS-69205
Targeting BRAT1 with Curcusone Diterpenoids and Analogs for Cancer Treatment
Technology No. 2021-DAI-69235
Novel Amination Method for Medicinally Important Compounds
Technology No. 2021-DAI-69172
pH-Activable Fluorescent Probes for Targeting Cell Organelles
Technology No. 2021-CHOP-69413
Single Crystal Matrix Isolation of Biopharmaceuticals for Enhanced Stability
Technology No. 2021-CHMI-69348
Novel inhalation formulations of polymyxins
Technology No. 2020-ZHOU-68990
Nano-composite Microparticles with Ivacaftor and Colistin
Technology No. 2020-ZHOU-68954
Quinolone-based Inhibitors of Lymphoid Tyrosine Phosphatase (PTPN22)
Technology No. 2020-ZHAN-68996
N-aryl oxamic acid based inhibitors for Mycobacterium Tuberculosis Protein Tyrosine Phosphatase B (mPTPB)
Technology No. 2020-ZHAN-68995
Griseofulvin Formulation for Therapy of Wet Macular Degeneration
Technology No. 2020-YEO-69132
Custom G4 Microarrays can Determine a Large-scale Ligand Binding Selectivity
Technology No. 2020-YANG-69054
Mixed Solvent Micelle Formulation Procedure
Technology No. 2020-WON-69093
Activity-Based Probes with Unnatural Amino Acids to Monitor the Proteasome in Live Cells
Technology No. 2020-TRAD-68937
Telescoped Continuous Flow Synthesis of an Alkynylnaphthyridine Anticancer Agent, HSN608
Technology No. 2020-THOM-69095
Monitoring ADME Proteins in Extracellular Vesicles for Drug Therapeutics
Technology No. 2020-TAO-69103
Cell Phone Integrated Paper Microfluidic Device for Colorimetric Multiplexed Detection of Analytical Targets
Technology No. 2020-STAN-68920
Tetrahydro-3H-pyrazolo[4,3-f]quinolone and tetrahydro-3H-pyrrolo[3,2-f]quinoline -Containing Compounds as Anticancer Agents
Technology No. 2020-SINT-69102
2,3-Disubstituted pyrido[3,4-b]pyrazine-containing Compounds as Kinase Inhibitors
Technology No. 2020-SINT-69073
Crystallization Method to Reduce Filtration Time of Agrochemicals
Technology No. 2020-NAGY-69085
Computational Method for Drug Screening using Molecular Surface Information
Technology No. 2020-KIHA-68981
Discovery of Potent Protease Inhibitors for Covid-19 Treatment using Specifically Designed Novel bis-amide Derivatives
Technology No. 2020-GHOS-69088
Discovery of Potent Anti-Mpro Inhibitors for Covid-19 Treatment using Alpha-ketoamide Derivatives
Technology No. 2020-GHOS-69045
Discovery of Potent Anti-Mpro Inhibitors for Covid-19 Treatment
Technology No. 2020-GHOS-69034
NOVEL COMPOUNDS FOR IMMUNOMODULATORY ACTIVITY
Technology No. 2020-CHOP-68949
Therapeutic Strategy by Drug Repositioning against Lowe Syndrome
Technology No. 2017-AGUI-67722
Tumbling Microrobots for in vivo Targeted Drug Delivery
Technology No. 2025-CAPP-70958
Long Acting Buprenorphine Implants
Technology No. 2024-OTTE-70416


























![Chromeno[4,3,2-de]isoquinolines as Potent Dopamine Receptor Ligands](https://storage.googleapis.com/elucid3-storage-1-us/uw/product/14379/2/chromeno432-deisoquinolines-as-potent-dopamine-receptor-ligands-01.jpg?mtime=20251204125631)














































































































![3H-pyrazolo[4,3-f]quinoline-based Compounds as STING Antagonists](https://storage.googleapis.com/elucid3-storage-1-us/uw/product/13269/2/3h-pyrazolo43-fquinoline-based-compounds-as-sting-antagonists-01.png?mtime=20251201115737)

























































![Tetrahydro-3H-pyrazolo[4,3-f]quinolone and tetrahydro-3H-pyrrolo[3,2-f]quinoline -Containing Compounds as Anticancer Agents](https://storage.googleapis.com/elucid3-storage-1-us/uw/product/13208/2/tetrahydro-3h-pyrazolo43-fquinolone-and-tetrahydro-3h-pyrrolo32-fquinoline--containing-compounds-as-anticancer-agents-01.png?mtime=20251202162718)
![2,3-Disubstituted pyrido[3,4-b]pyrazine-containing Compounds as Kinase Inhibitors](https://storage.googleapis.com/elucid3-storage-1-us/uw/product/13207/2/23-disubstituted-pyrido34-bpyrazine-containing-compounds-as-kinase-inhibitors-01.png?mtime=20251202163126)








